US Earnings Financial Results SEC Filings — March 24, 2026

24-03-2026

FTC Solar reported total revenue of $99.7M for FY 2025, up 110.5% YoY from $47.4M, driven by product revenue surging 114.0% to $80.3M and service revenue rising 97.0% to $19.4M. Gross loss narrowed significantly to $0.9M (-0.9% of revenue) from $12.6M (-26.6%), reflecting better cost control with total cost of revenue up only 67.8%. However, net loss widened to $79.6M from $48.6M, pressured by a $40.7M loss from warrant liability changes, interest expense ballooning to $8.2M (+1,134%), and operating expenses at $34.5M despite reductions in R&D and sales/marketing.

• ·Headcount increased 14.9% to 232, with Operations up to 107 (+15.1%), R&D to 55 (+22.2%), Sales/Marketing to 27 (+35%), but G&A flat at 43.
• ·Net cash from financing $40.4M in FY2025 vs $14.5M prior, driving cash increase of $9.9M vs $14.0M decrease.
• ·Gain from disposal of unconsolidated subsidiary $3.2M in FY2025 (down from $8.8M).

24-03-2026

Audax Private Credit Fund's investment portfolio expanded 46% to $949.8M at fair value as of December 31, 2025 from $651.0M at December 31, 2024, driven by $474.1M in new investments, with the number of portfolio investments rising to 116 from 43. Total investment income increased to $64.9M from $15.1M over the respective periods; however, weighted average yields declined to 8.28% from 10.07%, net unrealized losses of $5.8M were recorded versus $4.9M gains prior, and total expenses rose to $37.2M from $7.8M.

• ·Leverage facility committed increased to $600M from $500M; outstanding principal rose to $494.3M from $343.0M as of Dec 31 2025 vs 2024.
• ·Unitranche Debt at fair value: $589.1M (Dec 31 2025) vs $487.5M (Dec 31 2024); First Lien Debt: $295.1M vs $112.8M.
• ·Principal repayments: $166.5M (2025) vs $29.2M (2024 period).
• ·Commencement of operations: October 10, 2024.

24-03-2026

Ocean Thermal Energy Corp (CPWR) reported its first annual revenue of $3.0M in 2025, up from $0 in 2024, with gross profit of $0.6M and improved operating loss of $0.2M versus $1.6M prior year. However, a massive $66.2M unfavorable change in fair value of derivative liability drove net loss to $69.3M from $1.2M, ballooning total liabilities to $114.9M from $44.6M and stockholders' deficit to $113.4M from $44.6M amid going concern warnings and defaulted debt. Cash improved to $0.4M from $16K, supported by financing inflows.

• ·Operating cash use improved to $93K from $563K YoY.
• ·Interest expense increased to $2.9M from $2.5M.
• ·Accounts receivable arose at $1.1M in 2025.
• ·Common stock subscribed $447,500 in 2025.
• ·Cash paid for interest: $353K in 2025 vs $64K in 2024.

24-03-2026

The 10-K annual report for Benchmark 2020-B22 Mortgage Trust, filed March 24, 2026, assesses compliance with Regulation AB Rule 1122(d) servicing criteria by servicers including Midland and KeyBank. Most applicable criteria across general servicing, cash collection, investor remittances, and pool asset administration were performed directly or by responsible vendors, with no material non-compliance noted. However, numerous criteria are designated as N/A or not applicable due to the transaction structure, limiting the scope of assessment.

24-03-2026

Cantor Fitzgerald Income Trust, Inc. reported a net loss of $13.5M for the year ended December 31, 2025, including an $8.4M loss attributable to common stockholders and a $4.8M impairment on real estate investments. Funds from Operations were positive at $10.3M and Modified Funds from Operations at $8.4M; however, total distributions declined 15% YoY to $17.9M from $21.1M in 2024, fully funded by operating cash flows of $27.4M. Net Asset Value was $284.4M, or approximately $20.10 per share across share classes, with debt obligations at $565M.

• ·Cash flows from investing activities: -$10.9M
• ·Cash flows from financing activities: -$29.4M
• ·Stockholders’ equity under U.S. GAAP: $470.3M (Dec 31, 2025)
• ·Investment in infrastructure fund at fair value: $8.7M (Dec 31, 2025)
• ·Real estate depreciation and amortization: $35.8M

24-03-2026

Inflection Point Acquisition Corp. V, a SPAC, completed its IPO raising $86.25M in gross proceeds, funding a trust account of $89.3M at $10.36 per redeemable share, and reported net income of $397K for the year ended December 31, 2025, primarily from $3.1M interest income. However, it recorded a $2.7M operating loss from formation and operating costs, leading to a shareholders' deficit of $6.0M and only $26K cash outside the trust, with total assets growing to $89.5M from $0.13M prior period. Compared to the inception period through December 31, 2024, operating losses worsened significantly by approximately 35,200%, though offset by interest income.

• ·8,625,000 Class A ordinary shares subject to redemption at $10.36 per share.
• ·Deferred offering costs of $131,602 reclassified and paid in 2025.
• ·Net cash used in operating activities: $701K in 2025 vs provided $107K in prior period.
• ·IPO-related non-cash items include $13.3M remeasurement adjustment on redeemable shares and $7.8M allocated to public rights.

24-03-2026

Appendix B of BANK5's 10-K filing details compliance assertions for servicing criteria under Regulation AB across multiple entities involved in asset-backed securities servicing. The company and servicers like Midland, CoreLogic, and KeyBank confirm performance of most criteria in general servicing considerations, cash collection, and pool asset administration either directly or via responsible vendors. However, numerous investor remittances and reporting criteria (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) are marked as not performed, N/A, or inapplicable, particularly for certain platforms.

• ·Several criteria such as 1122(d)(1)(iii) (back-up servicer) and 1122(d)(4)(xv) (external enhancements) are explicitly not performed or N/A.
• ·Reconciliations for bank accounts must be prepared within 30 calendar days and reconciling items resolved within 90 calendar days.
• ·Funds held in escrow analyzed annually and returned within 30 calendar days of repayment.

24-03-2026

The 10-K annual report for Benchmark 2018-B7 Mortgage Trust, filed on March 24, 2026, contains compliance assertions under Regulation AB Item 1122 from servicers including KeyBank, PBLS1, and Green Loan Services LLC. These parties confirm adherence to most applicable servicing criteria for general servicing, cash collection, investor reporting, and pool asset administration, either directly or via responsible vendors, with certain criteria marked as N/A or not performed where inapplicable to their roles. No material instances of non-compliance or exceptions are disclosed.

24-03-2026

The 10-K annual report for JPMDB Commercial Mortgage Securities Trust 2019-COR6 assesses compliance with Regulation AB Item 1122 servicing criteria by Midland, CoreLogic, and other servicers. Applicable criteria were generally performed directly or via responsible vendors, with many others deemed N/A and no material non-compliance noted. The filing confirms adherence to transaction agreements across cash collection, investor reporting, and pool asset administration without highlighting any deficiencies.

• ·Filing date: March 24, 2026
• ·Multiple servicing criteria marked as N/A (e.g., back-up servicer requirements, investor remittances)
• ·Timeframes referenced include deposits/postings within 2 business days, reconciliations within 30 days, and resolution of reconciling items within 90 days

24-03-2026

The 10-K annual report for Benchmark 2020-B16 Mortgage Trust, filed March 24, 2026, contains Regulation AB 1122(d) servicing criteria compliance assessments by multiple servicers including Midland, Special Servicer, PBLS, and KeyBank. Across sections, most applicable criteria are reported as performed directly by the servicer or by vendors for which they are responsible, while others are designated N/A or inapplicable with no disclosed non-compliance exceptions. No financial performance metrics, delinquencies, or servicer changes are detailed.

24-03-2026

The 10-K annual report for CF 2019-CF3 Mortgage Trust details compliance assertions by servicers Midland, K-Star, PBLS, KeyBank, and the Asserting Party with Regulation AB servicing criteria (Item 1122) for the reporting period. Midland and KeyBank affirm compliance with most criteria directly or via responsible vendors, while K-Star and PBLS mark numerous criteria as not performed by them or their subservicers, reflecting their limited roles. No material non-compliance or exceptions are explicitly reported.

• ·Filing date: March 24, 2026
• ·Compliance assessed throughout the reporting period (exact period not specified)
• ·Standard timeframes referenced: 2 business days for deposits/postings, 30 calendar days for reconciliations/escrow returns, 90 calendar days for reconciling items

24-03-2026

The 10-K annual report for JPMCC Commercial Mortgage Securities Trust 2017-JP6, filed on March 24, 2026, details compliance assessments for servicing criteria under Regulation AB Item 1122 by servicer Midland and other asserting parties. Most applicable criteria across general servicing, cash collection, investor reporting, and pool asset administration are affirmed as performed directly (marked X) or by responsible vendors, with no material non-compliance noted. Several criteria are designated as N/A, inapplicable, or not performed by the asserting party, which is typical for structured ABS transactions.

24-03-2026

Polaryx Therapeutics reported a narrowed net loss of $9.0M for FY 2025 (70% improvement YoY from $30.4M), primarily due to the absence of $26.0M recapitalization costs from 2024, with EPS improving to $(0.20) from $(0.89). However, operating loss widened 80% YoY to $7.8M driven by R&D expenses more than doubling to $6.3M, while G&A remained flat at $1.6M; cash and equivalents grew 11% to $5.1M but operating cash burn increased 53% to $3.9M.

• ·Common shares outstanding increased to 47.3M from 41.2M YoY.
• ·Accumulated deficit grew to $(99.6M) from $(90.7M).
• ·Total liabilities rose to $605k from $289k, driven by higher accounts payable.

24-03-2026

The 10-K filing for Benchmark 2019-B10 Mortgage Trust includes assertions of compliance with Regulation AB Item 1122 servicing criteria by KeyBank, Midland, Special Servicer, and other parties, confirming that most applicable criteria were performed directly or via responsible vendors with no material deficiencies noted. Several criteria are marked as N/A or not applicable, particularly for investor reporting and remittances where responsibilities lie elsewhere. Overall, the report indicates standard operational compliance for the mortgage loan pool servicing.

• ·Filing date: March 24, 2026
• ·Compliance assessed for reporting period with timeframes such as 2 business days for deposits/postings, 30 calendar days for reconciliations/escrow returns, and 90 calendar days for reconciling items

24-03-2026

Achieve Life Sciences reported total assets of $41.8M as of Dec 31, 2025, up 8% from $38.6M in 2024, driven by cash and equivalents rising 64% to $20.9M following $45.1M net proceeds from June 2025 public offerings. However, net loss widened 37% YoY to $54.6M from $39.8M, with total operating expenses surging 40% to $54.9M primarily due to G&A doubling to $31.9M while R&D remained flat at ~$23M. Stockholders' equity edged up 3% to $21.5M amid ongoing cash burn of $49.5M in operations and a going concern note.

• ·Convertible debt increased to $14.9M ($3.7M current, $11.2M non-current) as of Dec 31 2025 from $9.8M in 2024.
• ·Marketable securities declined to $15.5M from $21.6M YoY.
• ·Basic and diluted net loss per share was $1.25 in 2025 (43.6M shares) vs $1.24 in 2024 (32.1M shares).
• ·Net cash provided by financing activities $51.5M in 2025 vs $48.5M in 2024.
• ·Going concern uncertainty noted in Note 1.

24-03-2026

Core & Main, Inc. reported FY2026 net sales of $7,647M, up 2.8% YoY from $7,441M, with growth in storm drainage products (+4.1%) and meter products (+3.5%), but fire protection products increased only 0.7% while pipes, valves & fittings grew modestly at 2.6%. Adjusted EBITDA was nearly flat at $931M versus $930M in FY2025, and operating income edged up slightly to $722M from $719M. Net income attributable to the company rose 7.3% to $441M from $411M, supported by lower interest expense.

• ·Cash and cash equivalents increased to $220M from $8M YoY.
• ·Long-term debt decreased to $2,124M from $2,237M.
• ·Cash flows from operating activities rose to $650M from $621M.
• ·2028 Senior Term Loan: $1,233M principal, matures July 27, 2028, weighted average interest rate 5.69%.
• ·Senior ABL Credit Facility borrowing capacity $1,250M, matures February 9, 2029.

24-03-2026

COMPASS Pathways plc reported a sharply widened net loss of $287.9M for the year ended December 31, 2025, compared to $155.1M in 2024, driven primarily by a $122.6M fair value loss on warrant liabilities, though operating expenses remained nearly flat at $179.0M versus $178.2M. Cash used in operating activities increased 32% to $157.2M from $119.2M, but strong financing inflows of $140.7M (up from $63.8M) led to a smaller net cash decrease of $15.5M versus $55.2M prior year. Balance sheet showed total assets slightly down to $210.3M from $213.7M, with shareholders' equity flipping to a $52.8M deficit from a $154.7M surplus.

• ·R&D tax credit benefit declined to $3.7M from $21.1M YoY.
• ·Interest income decreased to $7.2M from $8.3M.
• ·Diluted EPS worsened to $(3.08) from $(2.30).
• ·Ordinary shares outstanding increased to 96.1M from 68.6M.

24-03-2026

BioCardia, Inc.'s 10-K annual report filed on March 24, 2026, details regulatory risks from the Affordable Care Act, including increased Medicaid rebate liability from 15.1% to 23.1% of average manufacturer price (AMP) on branded drugs and biologics, expansion to managed care utilization, and an annual nondeductible fee on manufacturers since 2011. The filing extensively discloses business risks, such as a history of operating losses, need for substantial additional financing, uncertainties in FDA approval for the novel CardiAMP Cell Therapy System via premarket approval pathway, clinical trial delays, reliance on third-party manufacturers and suppliers, competition, and potential Nasdaq delisting. No financial performance metrics or period-over-period comparisons are provided in the excerpt.

• ·Filing Date: March 24, 2026
• ·No cell-based therapies approved in the United States for cardiac indications as of filing
• ·ACA changes effective 2010 (rebate increases, managed care expansion) and 2011 (annual nondeductible fee)
• ·Dependence on single or limited suppliers for key components and sub-assemblies
• ·HCW Sales Agreement mentioned for potential equity issuances

24-03-2026

Fractyl Health, Inc. reported zero revenue in 2025, down 100% from $93k in 2024, with gross profit also falling to zero from $43k. Net loss more than doubled to $141M from $69M (105% increase), driven by a 3.5% rise in operating expenses to $97M and a sharp swing in other income/expense to a $44M loss from a $25M gain. While cash and equivalents grew 21% to $82M bolstered by $105M in financing activities, net cash used in operations increased 38% to $90M.

• ·Common shares outstanding increased to 153.4M from 48.8M due to multiple offerings including a September 2025 offering of 60M shares netting $56M.
• ·Warrant liabilities rose to $36.4M from $1.3M as of Dec 31 2025.
• ·Adjusted EBITDA was -$89M in 2025 vs -$78M in 2024.
• ·Stock-based compensation expense declined to $6.7M from $14.4M.

24-03-2026

Neurogene Inc. reported a net loss of $90.4M for the year ended December 31, 2025, widening 20.2% YoY from $75.1M, driven by a 23.7% increase in total operating expenses to $103.3M, with R&D expenses up 23.1% to $75.0M and G&A up 25.3% to $28.3M; revenue dropped to $0 from $0.9M. Cash and cash equivalents declined 24.0% to $103.8M, with net cash used in operating activities worsening to $77.2M from $70.6M, though interest income rose 36.4% to $11.5M and financing activities provided $30.4M. Total assets fell 14.0% to $288.6M, and stockholders' equity decreased 14.7% to $264.9M.

• ·Net loss per share improved slightly to $(4.24) from $(4.28) YoY.
• ·Stock-based compensation expense increased to $14.2M in 2025 from $8.3M in 2024.
• ·Issuance of common stock in at-the-market offering: 1,200,000 shares for $30.3M net.
• ·Total CVR liability decreased to $1.1M from $1.8M.

24-03-2026

The 10-K annual report for CFCRE 2016-C4 Mortgage Trust, filed on March 24, 2026, includes multiple appendices and exhibits asserting compliance with Regulation AB servicing criteria (1122(d)(1)(i) through 1122(d)(2)(vii)) for general servicing considerations and cash collection/administration. Various parties, including the Company, CoreLogic, PBLS, and CWCAM, mark criteria as performed directly, by vendors, applicable, or inapplicable, with no exceptions or non-compliance noted. No financial performance metrics, advances, or quantitative discrepancies are reported.

• ·Filing covers compliance assertions for servicing criteria including monitoring triggers/events of default, custodial accounts at federally insured institutions, monthly reconciliations within 30 days, and safeguarding unissued checks.

24-03-2026

GameStop Corp. reported FY25 net sales of $3.63B, down 5.1% YoY from $3.82B, driven by declines in Hardware & accessories (-12.3%), Software (-27.5%), Canada (-81.3%), and Europe (-32.7%), though offset by Collectibles growth of 47.7%, US sales up 3.6%, and Australia up 22.2%. Net income surged 218.7% to $418.4M from $131.3M, fueled by gross profit expansion of 7.4% to 33.0% margin, SG&A reduction of 19.5%, and interest income growth, with cash and equivalents rising to $6.30B and total liquidity at $9.01B. Operating cash flow improved sharply to $614.8M from $145.7M.

• ·Asset impairments increased 454.6% to $53.8M in FY25.
• ·Loss on digital assets and related receivables of $131.6M in FY25.
• ·Long-term debt rose to $4,164.3M as of Jan 31, 2026 from $6.6M.
• ·Merchandise inventories declined to $403.3M from $480.2M.
• ·Operating lease right-of-use assets decreased to $183.3M from $374.1M.
• ·FY23 net sales were $5.27B, with net income of $6.7M.
• ·Diluted EPS $0.77 in FY25 vs $0.33 in FY24.

24-03-2026

Sanara MedTech Inc. (SMTI) filed its 10-K annual report on March 24, 2026, detailing extensive risk factors including a history of losses that may continue with sales expansion, challenges in revenue forecasting, intense competition, debt covenant compliance, regulatory hurdles, IP vulnerabilities, and reliance on third-party partners. Debt agreements mandate minimum liquidity of $3.0M and escalating annual minimum revenues: $60.0M for 2024, $75.0M for 2025, $85.0M for 2026, $95.0M for 2027, and $105.0M thereafter, with potential restrictions on cash flow usage and competitive disadvantages from high leverage. No actual financial performance metrics or period-over-period comparisons are provided in the excerpt.

• ·Debt covenants restrict business activities, require significant cash flow for debt service, and limit flexibility for working capital, capex, or acquisitions.
• ·CellerateRX Surgical lacks comprehensive patent protection, exposing it to competition from equivalent products.

24-03-2026

MV Oil Trust reported proved developed producing reserves of 262.2 MBbl oil, 6.3 MMcf gas, and 0.1 MBbl NGL, with 80% NPI net operating income of $5.1M. However, 2025 performance showed significant declines including trust income from NPI dropping 39% YoY to $11.3M from $18.6M in 2024, oil prices falling 14% to $61.85/Bbl, and standardized measure of discounted future net cash flows plunging 74% to $5.0M. Total assets decreased to $2.3M from $3.9M, reflecting ongoing reserve depletion and lower commodity prices.

• ·Future development costs: $0.0
• ·Cash distributions in 2025: $10.4M (down from $17.7M in 2024)
• ·Trust expenses in 2025: $1.0M
• ·Amortization of net profits interest in 2025: $1.5M
• ·Revisions of quantity estimates in 2025: +$1.1M (positive change in standardized measure)

24-03-2026

Capital One Prime Auto Receivables Trust 2023-2 filed its 10-K annual report on March 24, 2026, covering standard disclosures including Market for Common Equity (Item 5), Management's Discussion and Analysis (Item 7), Financial Statements (Item 8), and Controls and Procedures (Item 9A). No changes in accountants, disagreements, or other material information were reported under Items 9, 9B, or 9C. The filing confirms the issuing entity's incorporation in Delaware with principal offices in McLean, VA.

• ·State of Incorporation: Delaware
• ·Principal Executive Offices: 1600 Capital One Drive, Room 27907-B, McLean, VA 22102
• ·Telephone: (703) 720-3148
• ·I.R.S. Employer Identification No.: 93-6679317

24-03-2026

Capital One Prime Auto Receivables Trust 2025-1 filed its 10-K annual report on March 24, 2026, covering standard sections including Management's Discussion and Analysis, Financial Statements, and Controls and Procedures. The issuing entity is incorporated in Delaware with principal executive offices at 1600 Capital One Drive, Room 27907-B, McLean, VA 22102. No specific financial metrics, changes, or notable events are detailed in the provided filing excerpt.

• ·State of Incorporation: Delaware
• ·Address: c/o Capital One Auto Receivables, LLC, 1600 Capital One Drive, Room 27907-B, McLean, VA 22102
• ·Telephone: (703) 720-3148
• ·I.R.S. Employer Identification No.: 39-7243544

24-03-2026

Capital One Prime Auto Receivables Trust 2024-1 filed its 10-K annual report on March 24, 2026, covering standard sections including Management's Discussion and Analysis, Financial Statements, and disclosures on controls and procedures with no reported changes in accountants or other information. The issuing entity is a Delaware trust with principal executive offices c/o Capital One Auto Receivables, LLC in McLean, VA, and IRS Employer Identification No. 33-6396698. No specific financial metrics, period comparisons, or material events are detailed in the provided content.

• ·State of Incorporation: Delaware
• ·Principal Executive Offices: 1600 Capital One Drive, Room 27907-B, McLean, VA 22102
• ·Telephone: (703) 720-3148
• ·I.R.S. Employer Identification No.: 33-6396698
• ·Item 9B Other Information: None
• ·Item 9C Disclosure Regarding Foreign Jurisdictions: Not applicable

24-03-2026

VOC Energy Trust's 2025 annual results showed declining production volumes with total BOE down 4% YoY to 479,601 and oil sales volumes off 4% to 440,022 Bbl, driven by lower oil prices of $65.44/Bbl (-15% YoY) despite a 9% rise in gas prices to $3.22/Mcf, leading to gross proceeds of $29.6M (-17% YoY) and Trust income from net profits interest of $8.6M (-37% YoY). Cash distributions decreased sharply to $7.4M from $12.4M, reducing the Trust corpus to $10.4M. However, cash equivalents rose slightly to $2.0M and lease operating expenses per BoE dipped 0.2% YoY.

• ·Proved developed producing oil reserves: 1,495.2 MBbl
• ·Proved undeveloped oil reserves: 450.2 MBbl
• ·80% NPI net operating income total proved: $17.7M
• ·Lease operating expenses 2025: $14.1M (down 3% YoY)
• ·Development expenses 2025: $2.9M (up 18% YoY)

24-03-2026

BTC Development Corp. (BDCIU), a special purpose acquisition company (SPAC), filed its 10-K annual report on March 24, 2026, covering the years ended December 31, 2025 and 2024, with no initial business combination completed to date. Key disclosures include sponsor compensation of $30,000 per month for services, 8,686,667 Class B ordinary shares issued for $25,000, and 512,500 placement units for $5.125M, alongside founder share lock-up restrictions until one year post-business combination or share price triggers. Financial statements are included comparing 2025 and 2024, but specific performance metrics show no growth or declines as no operational business exists yet.

• ·Permitted withdrawals from trust account limited to interest earned, up to $400,000 annually for working capital and taxes (excluding excise taxes).
• ·Founder shares subject to transfer restrictions until earliest of one year post-business combination or Class A share price >= $12.00 for 20 trading days in 30-day period starting 150 days after combination.
• ·Sponsor and affiliates may receive finder's fees, advisory fees from funds outside trust account prior to business combination.

24-03-2026

The 10-K filing for GS Mortgage Securities Trust 2015-GC34 includes management's assertions on compliance with Regulation AB servicing criteria (Item 1122(d)), with most criteria such as monitoring triggers, custodial account maintenance, and fidelity bonds marked as performed directly by the company or asserting party. Some criteria, including back-up servicer maintenance and certain cash collection procedures, are noted as inapplicable or not performed. CoreLogic provides separate assertions confirming compliance for select criteria like fidelity bonds and disbursements, while listing applicability for numerous student loan and credit card trusts.

• ·Filing date: March 24, 2026
• ·Specific inapplicable/not performed criteria include 1122(d)(1)(iii) (back-up servicer), 1122(d)(2)(vii) (reconciliations for Platforms A and B), and several cash collection criteria for CoreLogic

24-03-2026

Biomea Fusion, Inc. reported a significantly reduced net loss of $61.8M for the year ended December 31, 2025, compared to $138.4M in 2024, primarily due to a 42% decrease in total operating expenses to $83.5M, with R&D expenses dropping 48% to $62.0M. However, cash and cash equivalents declined slightly to $55.8M from $58.3M, total assets fell 27% to $58.6M, and stockholders' equity decreased to $29.6M from $51.6M amid a $70.4M cash burn from operations and a $2.2M impairment charge. The company raised $67.9M from financing activities, doubling common shares outstanding to 72.3M.

• ·Weighted-average common shares basic and diluted: 52,228,068 in 2025 vs 36,105,671 in 2024.
• ·Net loss per common share: $(1.18) in 2025 vs $(3.83) in 2024.
• ·Stock-based compensation expense: $9.5M in 2025 vs $19.1M in 2024.
• ·Issuance costs in 2025 public offerings: $4.9M.

24-03-2026

The 10-K annual report for Morgan Stanley Bank of America Merrill Lynch Trust 2016-C30 includes Appendix B, which provides servicing criteria compliance assertions under Regulation AB 1122(d) by multiple servicers and vendors. Various parties assert that applicable criteria related to general servicing, cash collection, investor reporting, and pool asset administration are performed directly or via responsible vendors, while others are marked as inapplicable or not performed, such as back-up servicer maintenance and certain investor remittance details. No exceptions, material weaknesses, or quantitative performance issues are disclosed.

24-03-2026

Strategic Storage Trust VI, Inc. reported total assets of $757.1M as of September 30, 2025, up 10.9% from $682.0M at March 31, 2024, driven by real estate investments growing to $738.4M (+13.6%) and NAV increasing 20.6% to $273.2M, while NAV per share remained stable at $10.00 across share classes. For the year ended December 31, 2025, revenues rose 8.8% YoY to $30.7M with NOI up 11.6% to $17.3M; however, the company posted a net loss of $24.0M (improved from $35.6M prior year), cash from operations deteriorated to $(19.8M), and distributions of $28.5M (+8.6%) were entirely funded by offering proceeds rather than operations. Same-store occupancy declined 1.0% to 90.3%, though average rent per sq ft increased 3.2%.

• ·Same-store revenues +4.6% YoY to $14.2M, but property operating expenses -1.1%; non same-store expenses +10.5% implied.
• ·Debt increased to $292.0M from $284.5M; Series D Preferred Units added $25M.
• ·NAV allocated to Class Y shares grew to $54.2M from $14.4M, with shares outstanding +276%; Class Z to $5.7M from $1.2M.

24-03-2026

ECA Marcellus Trust I's royalty income surged 73% YoY to $3.8M in 2025 from $2.2M in 2024, boosting distributable income to $2.2M ($0.128 per unit) from $0.8M ($0.045 per unit) and improving the standardized measure of discounted future net cash flows to $17,576 from $9,689. However, net royalty interest declined 11% to $9.1M from $10.3M, proved natural gas reserves fell 4% to 14,944 MMcf from 15,548 MMcf, and trust corpus decreased 5% to $12.7M from $13.4M. Total assets slightly dipped to $13.3M from $13.7M amid ongoing amortization.

• ·No impairment charge recorded in 2025 or 2024.
• ·General and administrative expense decreased to $1.2M from $1.2M (5% decline).
• ·Cash reserves withheld by Trustee: $360,000 in 2025 vs $168K in 2024.
• ·Amortization of royalty interest: $1.1M in both years (flat).

24-03-2026

The 10-K annual report for Capital One Multi Asset Execution Trust, filed on March 24, 2026, provides organizational details for Delaware and New York issuing entities, both c/o Capital One Funding, LLC at 1600 Capital One Drive, Room 27907-A, McLean, VA 22102, with telephone (804) 284-2500. Item 9B reports no other information, and Item 9C is not applicable. No financial statements, performance metrics, or period-over-period comparisons are included in the provided content.

• ·Jurisdictions: Delaware and New York
• ·I.R.S. Employer Identification No.: Not Applicable (both entities)
• ·Standard 10-K sections listed: Items 5 through 9C

24-03-2026

Discover Funding LLC filed its 10-K Annual Report on March 24, 2026, listing standard sections including MD&A, Financial Statements, and Controls and Procedures. Item 9B reports no other information, and Item 9C is not applicable. Issuer details confirm incorporation in Delaware with principal offices at 800 Prides Crossing, Suite 100, Newark, Delaware 19713.

• ·State of Incorporation: Delaware
• ·Telephone: (302) 323-7315
• ·I.R.S. Employer Identification No.: Not Applicable

24-03-2026

LENZ Therapeutics reported first-year revenue of $19.1M for 2025, including $17.5M license revenue and $1.6M product sales net, versus zero in 2024, marking commercial launch progress. However, net loss expanded 65% to $82.1M from $49.8M, driven by SG&A expenses surging 216% to $91.1M, while R&D expenses declined 37% to $18.7M. Balance sheet strengthened with total assets at $305.9M (up 42%) and stockholders' equity at $284.3M (up 39%), supported by $149.7M in financing inflows, though operating cash use rose to $69.2M.

• ·Net cash provided by financing activities: $149.7M in 2025 vs $199.0M in 2024.
• ·Weighted-average common shares outstanding: 28.8M in 2025 vs 21.3M in 2024.
• ·Net loss per share: $(2.85) basic and diluted in 2025 vs $(2.34) in 2024.
• ·Accumulated deficit: $(227.1M) at Dec 31, 2025 vs $(145.0M) at Dec 31, 2024.

24-03-2026

G-III Apparel Group's FY2026 net sales declined 7% YoY to $2.96B from $3.18B, with gross profit dropping 10% to $1.16B (margin 39.4% vs 40.8%) and operating profit plunging 63% to $108M due to $49M in asset impairments (up from $8M). While Karl Lagerfeld sales grew 9% YoY to $630M, DKNY sales fell 4% to $650M, and net income decreased 65% to $67M. International sales were $672M or 23% of total net sales.

• ·Calvin Klein licenses expire staggered starting Dec 31, 2024 through 2027; Tommy Hilfiger starting Dec 31, 2025 through 2027.
• ·Upcoming license expirations in FY2026: Dec 31, 2025 ($436M or 15% of net sales), Dec 31, 2026 ($372M or 13%), Dec 31, 2027 ($19M or 1%).
• ·DKNY founded 1989, acquired by G-III 2016; Karl Lagerfeld full acquisition 2022 (North America launch 2015).
• ·By FY2020, Calvin Klein licensed products exceeded $1B annual net sales; Tommy Hilfiger $500M.

24-03-2026

Capital One Prime Auto Receivables Trust 2022-1, a Delaware-incorporated issuing entity (EIN 84-6904808), filed its 10-K annual report on March 24, 2026. The filing covers standard sections including Management's Discussion and Analysis, Financial Statements, and disclosures on controls, procedures, and market risk, with no reported changes in accountants, disagreements, or other material information in Items 9-9C. No quantitative financial performance data, period comparisons, or notable positives/negatives are detailed in the provided content.

• ·Principal executive offices: 1600 Capital One Drive, Room 27907-B, McLean, VA 22102
• ·Telephone: (703) 720-3148
• ·State of incorporation: Delaware
• ·I.R.S. Employer Identification No.: 84-6904808

24-03-2026

Capital One Prime Auto Receivables Trust 2022-2 filed its 10-K annual report on March 24, 2026, covering standard sections including Management's Discussion and Analysis (Item 7), Financial Statements (Item 8), and Controls and Procedures (Item 9A). No changes or disagreements with accountants (Item 9) and no other information (Item 9B: None) or foreign jurisdiction disclosures (Item 9C: Not applicable) were reported.

• ·Incorporated in Delaware; principal offices at 1600 Capital One Drive, Room 27907-B, McLean, VA 22102
• ·Telephone: (703) 720-3148
• ·I.R.S. Employer Identification No.: 84-6908764

24-03-2026

Grayscale Sui Staking ETF (GSUI), formerly Grayscale Sui Trust (SUI), filed its 10-K for FY ended December 31, 2025, reporting it holds approximately 0.08% of circulating SUI, with each Share representing 14.4785 SUI as of that date, and 1,718,900 Shares outstanding as of March 19, 2026. The Trust uplisted to NYSE Arca on February 18, 2026, commenced staking on the same date, and shifted to a single sponsor (GSIS) effective May 3, 2025; however, prior to uplisting, Shares traded at substantial premiums (avg 29%, max 38%) and discounts (avg 11%, max 30%) to NAV on OTCQB from November 24 to December 31, 2025, including a 3% discount on December 31, 2025.

• ·Trust formed April 30, 2024; name changed February 17, 2026.
• ·SEC approved NYSE Arca generic listing standards September 17, 2025.
• ·Reorganization January 1, 2025; GSO withdrew January 3, 2025.

24-03-2026

The 10-K filing for BANK 2019-BNK20 includes Appendix B asserting compliance with Regulation AB 1122(d) servicing criteria, where the primary servicer directly performs or oversees most criteria in general servicing considerations, cash collection, and pool asset administration. However, several investor remittances and reporting criteria (e.g., 1122(d)(3)(i)-(iv)) and specific pool asset tasks are marked as not performed by the company or its responsible vendors, with assertions from subservicers like PBLS1 and CoreLogic showing limited direct responsibility in their scopes. No material non-compliance is noted, confirming adherence where applicable.

• ·Back-up servicer maintenance (1122(d)(1)(iii)) marked as not performed across assertions.
• ·Pool asset documents safeguarding (1122(d)(4)(ii)) not performed by primary servicer but handled in some subservicer tables.
• ·External enhancements/support (1122(d)(4)(xv)) consistently not performed.

24-03-2026

Revenue exploded 2,387% YoY to $38.6M in 2025 from $1.6M in 2024, primarily driven by China segment ($35.2M from $0) and new Customers C ($10.4M, 27%) and D ($23.8M, 61.5%). However, net loss ballooned 238% to $(206.9M) from $(61.2M), with operating expenses surging to $110.0M from $48.6M due to R&D (+69.5%) and SG&A (+140.7%), while Japan revenue plummeted to $3k from $332k and Adjusted EBITDA deteriorated 18% to $(50.5M). Total assets reached $102.2M with stockholders' equity turning positive at $39.0M, though cash declined to $45.8M.

• ·Note 2 addresses Liquidity and Going Concern.
• ·Customer A represented 76.8% of 2024 revenue but $0 in 2025.
• ·Stock-based compensation surged to $37.5M from $3.8M (+876%).
• ·Total current liabilities fell to $43.4M from $186.1M, aided by payoff of legacy convertible notes.

24-03-2026

Capital One Prime Auto Receivables Trust 2023-1 filed its 10-K annual report on March 24, 2026, covering standard sections including Market for Registrant’s Common Equity (Item 5), Management's Discussion and Analysis (Item 7), Financial Statements (Item 8), and Controls and Procedures (Item 9A). No specific financial metrics, period-over-period comparisons, improvements, declines, or flat performance are detailed in the provided excerpt. The issuing entity is a Delaware-incorporated trust managed c/o Capital One Auto Receivables, LLC in McLean, VA.

• ·State of Incorporation: Delaware
• ·Principal Executive Offices: 1600 Capital One Drive, Room 27907-B, McLean, VA 22102
• ·Telephone: (703) 720-3148
• ·I.R.S. Employer Identification No.: 92-6150068

24-03-2026

The 10-K filing for Morgan Stanley Capital I Trust 2016-UBS12 details servicing compliance assertions under Regulation AB Item 1122(d) by multiple parties including Midland, PBLS, CoreLogic, and others, confirming adherence to most general servicing, cash collection, investor reporting, and pool asset administration criteria either directly or via responsible vendors. Several criteria are marked as N/A or inapplicable, such as back-up servicer requirements and certain investor remittance procedures, with no material non-compliance noted. This annual compliance report provides assurance on servicing practices without quantitative performance metrics or identified deficiencies.

• ·Multiple servicing criteria marked N/A or inapplicable, including 1122(d)(1)(iii) back-up servicer maintenance and various investor remittance criteria like 1122(d)(3)(ii)-(iv).

24-03-2026

The 10-K filing for Morgan Stanley Bank of America Merrill Lynch Trust 2013-C9, dated March 24, 2026, contains servicing compliance assertions from Midland, the Asserting Party, and Berkadia under Rule 1122(d). Most servicing criteria across general servicing, cash collection, investor reporting, and pool asset administration are affirmed as performed directly or by responsible vendors, demonstrating strong overall compliance. However, several criteria are marked N/A (e.g., back-up servicer requirements, certain investor reporting) or not performed by specific parties (e.g., loss mitigation by Berkadia), with handling shifted to non-responsible subservicers.

• ·Compliance assertions cover the reporting period ending prior to March 24, 2026.
• ·Standard timeframes referenced include deposits/postings within 2 business days, reconciliations within 30 calendar days, and resolution of reconciling items within 90 calendar days.
• ·N/A criteria include 1122(d)(1)(iii) back-up servicer (all parties), multiple investor remittance criteria for Asserting Party, and external enhancements 1122(d)(4)(xv).

24-03-2026

The 10-K annual report for Morgan Stanley Capital I Trust 2018-H4, filed March 24, 2026, asserts compliance by multiple servicers (Midland, Special Servicer, PBLS, KeyBank, and the Company) with Regulation AB Rule 1122(d) servicing criteria across categories like general servicing, cash collection, investor reporting, and pool asset administration. Most applicable criteria are marked as performed directly or by responsible vendors, with no material deficiencies noted; several are designated N/A or inapplicable depending on the servicer's role. No financial performance metrics, declines, or non-compliance issues are reported.

24-03-2026

The 10-K annual report for Morgan Stanley Capital I Trust 2015-UBS8 details compliance assessments for Regulation AB servicing criteria (Item 1122) by servicers including Midland, PBLS, CoreLogic, and others. Applicable criteria are affirmed as performed directly or by responsible vendors, while many investor reporting, remittances, and certain pool administration criteria are marked N/A or not performed by specific parties. No material servicing deficiencies, defaults, or non-compliance issues are reported.

• ·Multiple servicing criteria marked N/A, including back-up servicer maintenance (1122(d)(1)(iii)), certain investor reporting sub-items (1122(d)(3)(i)(B)-(D)), remittances (1122(d)(3)(ii)-(iv)), and external enhancements (1122(d)(4)(xv)).
• ·Filing date: March 24, 2026

24-03-2026

The 10-K annual report for Morgan Stanley Bank of America Merrill Lynch Trust 2017-C33, filed on March 24, 2026, includes Appendix B assessing compliance with Regulation AB Rule 1122(d) servicing criteria. Multiple servicers, including the primary servicer, Midland, PBLS1, KeyBank, and CoreLogic, confirm that most applicable criteria across general servicing, cash collection, investor reporting, and pool asset administration are performed directly or by responsible vendors, while several investor remittance and reporting criteria are marked as N/A or not performed by certain parties. No material deficiencies, exceptions, or servicer changes are disclosed.

24-03-2026

Bright Mountain Media, Inc. reported FY2025 revenue of $59.2M, up 4% YoY from $56.7M, with Adjusted EBITDA improving sharply to $3.0M from $0.8M and net loss narrowing 21% to $13.5M from $17.0M, driven by a 23% reduction in G&A expenses. However, gross margin declined 4% to $15.8M amid an 8% rise in cost of revenue, and the balance sheet deteriorated with current liabilities surging to $116.2M from $33.8M, widening the net working capital deficit to $95.5M from $13.5M.

• ·Cash flow from operating activities declined to $1.3M from $1.9M YoY.
• ·Publisher costs within cost of revenue rose 22% to $15.1M.
• ·Legal fees in G&A dropped 56% to $1.2M.
• ·Interest expense slightly decreased 3% to $12.3M.